Krystexxa®

Krystexxa® is a prescription medication administered via infusion therapy to help treat chronic refractory gout. The medication lowers uric acid levels and has been shown to remove years of uric acid buildup in the body. Your doctor may prescribe Krystexxa® when other methods of treatment have failed at improving symptoms of chronic gout, including pain and swelling.

About Krystexxa®

Krystexxa® was approved by the FDA in 2010 for the treatment of chronic gout and its symptoms. It’s the only treatment for chronic gout that helps control symptoms by changing uric acid into allantoin—a water-soluble substance that is flushed from the body when you urinate.

Doctors may prescribe Krystexxa® to patients who have not had success with other treatments to control their symptoms of gout. Krystexxa® has been shown to lower uric acid levels within the first day of receiving treatment, and patients have had success in completely clearing visible tophi.

Conditions treated by Krystexxa®

Krystexxa® is approved by the Food and Drug Administration (FDA) to treat patients with chronic gout. This painful disease develops from a build-up of uric acid levels in the body. Uric acid forms sharp crystals within the joints, most commonly the big toe, which leads to inflammation and intense pain associated with gout.

Gout attacks are often attributed to diets high in purine. Red meats, some seafoods, sugar, and alcohol all contain higher levels of purine and have been associated with the development of gout when consumed in large amounts. However, congestive heart failure, obesity, kidney disease, hypertension, diabetes, and family history can also increase your risk of developing gout.

What to Expect with Krystexxa® Infusion Therapy

When you receive Krystexxa® as a treatment for chronic gout, you are likely to get an infusion once every other week for six months. The exact course of treatment will be decided by your doctor and based on your individual medical needs.

Before treatment, your doctor may require a lab test to measure your uric acid levels. Unlike other infusion centers, FlexCare Infusion Centers provide on-site, day-of uric acid testing. That means you don’t have to schedule another appointment before you receive treatment.

FlexCare is a Gout Center of Excellence for our prescribed and managed immunomodulation for better treatment outcomes, Krystexxa-trained nursing staff, and close case management.

Getting Started With Infusion Therapy

If you have chronic gout and haven’t had success with other medications, talk to your doctor about Krystexxa® IV therapy at FlexCare Infusion Centers.

Have your doctor submit a referral by email or fax. Our team will contact you within 24 hours of referral receipt.

Have Questions?

If you have any questions about thyroid eye disease or infusion therapy, contact us directly. We look forward to helping you on your journey to better health.